← Eichor
Condition: Relapsed Refractory B Cell Mediated Autoimmune Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Relapsed Refractory B Cell Mediated Autoimmune Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT07148791Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Ruijin Hospital · NCT07322718
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.